Creative Planning’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$195K Sell
24,273
-1,055
-4% -$10.1K ﹤0.01% 3745
2025
Q4
$295K Sell
25,328
-1,847
-7% -$18K ﹤0.01% 3248
2025
Q3
$273K Sell
27,175
-10,429
-28% -$150K ﹤0.01% 3218
2025
Q2
$656K Buy
37,604
+4,485
+14% +$64.7K ﹤0.01% 2227
2025
Q1
$417K Buy
33,119
+2,913
+10% +$35K ﹤0.01% 2465
2024
Q4
$319K Sell
30,206
-5,057
-14% -$70.8K ﹤0.01% 2611
2024
Q3
$511K Buy
35,263
+2,307
+7% +$27.4K ﹤0.01% 2089
2024
Q2
$280K Buy
32,956
+594
+2% +$5.27K ﹤0.01% 2409
2024
Q1
$331K Buy
32,362
+1,161
+4% +$8.66K ﹤0.01% 2174
2023
Q4
$171K Buy
31,201
+3,270
+12% +$14.3K ﹤0.01% 2478
2023
Q3
$106K Buy
+27,931
New +$183K ﹤0.01% 2390

Other funds holding SPRY